LEI 549300DAQ1CVT6CXN342

NOVO NORDISK A/S

Awards tracked

62

Value

€2.76M

Countries

DK

Download sample CSV

Contract awards & public grants

FORTIFY - FRAMEWORK FOR OPTIMIZED REGULATION, TRADE SECRETS, AND INTELLECTUAL PROPERTY IN A FEDERATED EUROPEAN HEALTH DATA SPACE → NOVO NORDISK A/S

European Commission · DK · Grant · 2026-06-02

—

Protein-ligand data generation at scale to support computational hit finding and optimization → NOVO NORDISK A/S

European Commission · DK · Grant · 2025-12-17

—

Cities@Heart: City-based Strategies for improving Cardiovascular Health in Europe → NOVO NORDISK A/S

European Commission · DK · Grant · 2025-12-17

—

Patient Relevant Osteoarthritis endpoints using Big data Evaluation → NOVO NORDISK A/S

European Commission · DK · Grant · 2025-12-02

—

Breakthrough Regulatory Innovation and Development throuGh sandbox Environments → NOVO NORDISK A/S

European Commission · DK · Grant · 2025-11-07

—

Unifying Framework for Patient-centred Clinical-study Endpoints derived from Digital Health Technologies → NOVO NORDISK A/S

European Commission · DK · Grant · 2025-11-03

—

Understanding and Postponing Yeast Death to Improve Production → NOVO NORDISK A/S

European Commission · DK · Grant · 2025-07-08

—

Machine Learning Computational Advancements for peRsonalized mEdicine → NOVO NORDISK A/S

European Commission · DK · Grant · 2025-06-20

—

Regenerative Medicine and Advanced Medicinal Therapeutic Products United for PhD excellence → NOVO NORDISK A/S

European Commission · DK · Grant · 2025-05-08

—

Collaborative Action and Research for Engagement, Persistence and Adherence in Treatment & Health → NOVO NORDISK A/S

European Commission · DK · Grant · 2025-05-08

—

Testing, improving, and co-creating Guidance and Tools for Real World Evidence Generation in Europe and use for Decision-Making in Europe: GREG → NOVO NORDISK A/S

European Commission · DK · Grant · 2025-04-28

—

EuroHeartPath: Leading Innovation in Cardiovascular Pathways for Improved Patient Outcomes → NOVO NORDISK A/S

European Commission · DK · Grant · 2025-01-16

—

Propelling the shift toward the future of circular, safe and sustainable packaging and single use device ecoDesigned solutions through healthcare envi → NOVO NORDISK A/S

European Commission · DK · Grant · 2024-12-18

—

Comprehensive methodological and operational approach to clinical trials in rare and ultra-rare diseases → NOVO NORDISK A/S

European Commission · DK · Grant · 2024-12-12

—

Advancing Safe and Sustainable by design Practices in Pharmaceutical Manufacturing → NOVO NORDISK A/S

European Commission · DK · Grant · 2024-12-05

—

REpresentative Clinical Research - ADvancing Inclusivity in Europe → NOVO NORDISK A/S

European Commission · DK · Grant · 2024-12-05

—

Reducing Non-Human Primates in Non-Clinical Safety Assessment: The European Initiative on Minipig and Micropig Models → NOVO NORDISK A/S

European Commission · DK · Grant · 2024-11-12

—

Interdisciplinary Marie Skłodowska-Curie Action for Health → NOVO NORDISK A/S

European Commission · DK · Grant · 2024-09-13

—

Synthetic Data Generation Framework for Integrated Validation of Use Cases and AI Healthcare Applications → NOVO NORDISK A/S

European Commission · DK · Grant · 2024-08-09

—

Developing and implementing VIrtual Control groups To reducE animal use in toxicology Research → NOVO NORDISK A/S

European Commission · DK · Grant · 2024-07-26

—

Macrocycles for Drug Discovery → NOVO NORDISK A/S

European Commission · DK · Grant · 2024-07-10

—

AI in Parkinson's Disease → NOVO NORDISK A/S

European Commission · DK · Grant · 2024-07-08

—

European Training Program for Deconvolution of Multi-scale Cilia Function in Health and Disease by Integrating Machine Learning-AI Approaches. → NOVO NORDISK A/S

European Commission · DK · Grant · 2024-06-25

—

A Biomarker-Based Platform for Early Diagnosis of Chronic Liver Disease to Enable Personalized Therapy → NOVO NORDISK A/S

European Commission · DK · Grant · 2023-11-27

—

GRIP on MASH: Global Research Initiative for Patient Screening on MASH → NOVO NORDISK A/S

European Commission · DK · Grant · 2023-11-27

—

PREDICTION OF ALZHEIMER’S DISEASE USING AN AI DRIVEN SCREENING PLATFORM → NOVO NORDISK A/S

European Commission · DK · Grant · 2023-10-30

—

Combining CT diagnostic data and interventional approaches for futureproof cardiology care → NOVO NORDISK A/S

European Commission · DK · Grant · 2023-10-27

—

European action for the Diagnosis of Early Non-clinical Type 1 diabetes For disease Interception → NOVO NORDISK A/S

European Commission · DK · Grant · 2023-10-27

—

INDIVIDUALISED CARE FROM EARLY RISK OF CARDIOVASCULAR DISEASE TO ESTABLISHED HEART FAILURE → NOVO NORDISK A/S

European Commission · DK · Grant · 2023-10-20

—

European Network on the Supramolecular Chemistry of Carbohydrates → NOVO NORDISK A/S

European Commission · DK · Grant · 2023-07-12

—

Intrinsically disordered proteins in health and disease: mechanisms, molecular context and opportunities for drug discovery → NOVO NORDISK A/S

European Commission · DK · Grant · 2023-07-05

—

Real-world evidence for decisions in diabetes → NOVO NORDISK A/S

European Commission · DK · Grant · 2022-11-22

€150,000

Development of a multifunctional biomaterial patch for buccal delivery of peptide-analogue treatments → NOVO NORDISK A/S

European Commission · DK · Grant · 2022-11-18

€430,688

Next generation toolbox for greener pharmaceuticals design & manufacturing towards reduced environmental impact → NOVO NORDISK A/S

European Commission · DK · Grant · 2022-05-22

€424,250

Shortening the path to rare disease diagnosis by using newborn genetic screening and digital technologies → NOVO NORDISK A/S

European Commission · DK · Grant · 2021-10-13

—

BEhavioral and Adherence Model for improving quality, health outcomes and cost-Effectiveness of healthcaRe → NOVO NORDISK A/S

European Commission · DK · Grant · 2021-09-27

—

Central Repository for Digital Pathology → NOVO NORDISK A/S

European Commission · DK · Grant · 2020-11-26

—

Accelerating Research & Development for Advanced Therapies → NOVO NORDISK A/S

European Commission · DK · Grant · 2020-11-11

—

Surface Integrity for Micro/Nano Processing of Polymers: A European Research Training Network for High-Performance Medical Devices → NOVO NORDISK A/S

European Commission · DK · Grant · 2020-08-17

€297,522

Stratification of Obesity Phenotypes to Optimize Future Therapy → NOVO NORDISK A/S

European Commission · DK · Grant · 2020-05-26

—

Translational approaches to disease modifying therapy of type 1 diabetes - HARVESTing the fruits of INNODIA → NOVO NORDISK A/S

European Commission · DK · Grant · 2020-04-16

—

PharmaLedger → NOVO NORDISK A/S

European Commission · DK · Grant · 2019-12-16

—

Novel Strategies for Cell-based Neural Reconstruction → NOVO NORDISK A/S

European Commission · DK · Grant · 2019-12-11

€300,000

EU Patient- cEntric clinicAl tRial pLatform → NOVO NORDISK A/S

European Commission · DK · Grant · 2019-11-27

—

Trials@Home: Center of Excellence – Remote Decentralised Clinical Trials → NOVO NORDISK A/S

European Commission · DK · Grant · 2019-08-07

—

Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed w → NOVO NORDISK A/S

European Commission · DK · Grant · 2019-05-06

—

EBiSC2 – A sustainable European Bank for induced pluripotent Stem Cells → NOVO NORDISK A/S

European Commission · DK · Grant · 2019-02-28

—

Investigating Mechanisms and Models Predictive of Accessibility of Therapeutics (IM2PACT) Into The Brain → NOVO NORDISK A/S

European Commission · DK · Grant · 2018-12-14

—

PET Imaging of Alpha-Synuclein Fibril Formation → NOVO NORDISK A/S

European Commission · DK · Grant · 2018-08-30

—

Ensuring the future of EUPATI beyond 2020 → NOVO NORDISK A/S

European Commission · DK · Grant · 2018-06-21

—

Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medici → NOVO NORDISK A/S

European Commission · DK · Grant · 2018-06-04

—

Hypoglycaemia - REdefining SOLutions for better liVEs → NOVO NORDISK A/S

European Commission · DK · Grant · 2018-04-30

—

Liver Investigation: Testing Marker Utility in Steatohepatitis → NOVO NORDISK A/S

European Commission · DK · Grant · 2017-10-09

—

European Research Training to Decipher The Ub Code : identification of potential biomarkers and drug targets → NOVO NORDISK A/S

European Commission · DK · Grant · 2017-08-17

€290,082

Imaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106 → NOVO NORDISK A/S

European Commission · DK · Grant · 2017-03-10

—

Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055 → NOVO NORDISK A/S

European Commission · DK · Grant · 2017-01-30

—

Biomarker Enterprise to Attack DKD - Sofia ref.: 115974 → NOVO NORDISK A/S

European Commission · DK · Grant · 2016-12-20

—

Unraveling Principles of PDZ-mediated Cell Signaling → NOVO NORDISK A/S

European Commission · DK · Grant · 2016-08-10

€580,164

Assessing risk and progression of prediabetes and type 2 diabetes to enable disease modification - Sofia ref.: 115881 → NOVO NORDISK A/S

European Commission · DK · Grant · 2016-06-07

—

Translational approaches to disease modifying therapy of type 1 diabetes: an innovative approach towards understanding and arresting type 1 diabetes – → NOVO NORDISK A/S

European Commission · DK · Grant · 2015-12-07

—

Accelerated Development of Appropriate Patient Therapies: a Sustainable, Multi-stakeholder Approach from Research to Treatment-outcomes - Sofia ref.: → NOVO NORDISK A/S

European Commission · DK · Grant · 2015-09-02

—

Multi-Stimuli Responsive Molecular Systems and Materials → NOVO NORDISK A/S

European Commission · DK · Grant · 2014-12-16

€290,082

Entity identity is matched from published recipient names and registry IDs to GLEIF legal-entity records; matches can be imperfect. Source records are public procurement and grant notices.